368 related articles for article (PubMed ID: 21838667)
1. 12-lipoxygenase: a potential target for novel anti-platelet therapeutics.
Yeung J; Holinstat M
Cardiovasc Hematol Agents Med Chem; 2011 Jul; 9(3):154-64. PubMed ID: 21838667
[TBL] [Abstract][Full Text] [Related]
2. Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy.
Tourdot BE; Holinstat M
Trends Pharmacol Sci; 2017 Nov; 38(11):1006-1015. PubMed ID: 28863985
[TBL] [Abstract][Full Text] [Related]
3. An anti-platelet agent, OPC-29030, inhibits translocation of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid production in human platelets.
Ozeki Y; Nagamura Y; Ito H; Unemi F; Kimura Y; Igawa T; Kambayashi Ji; Takahashi Y; Yoshimoto T
Br J Pharmacol; 1999 Dec; 128(8):1699-704. PubMed ID: 10588925
[TBL] [Abstract][Full Text] [Related]
4. 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets.
Yeung J; Tourdot BE; Adili R; Green AR; Freedman CJ; Fernandez-Perez P; Yu J; Holman TR; Holinstat M
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2068-77. PubMed ID: 27470510
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk.
Fuentes E; Wehinger S; Trostchansky A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830261
[TBL] [Abstract][Full Text] [Related]
6. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.
Yeung J; Li W; Holinstat M
Pharmacol Rev; 2018 Jul; 70(3):526-548. PubMed ID: 29925522
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.
Yeung J; Apopa PL; Vesci J; Kenyon V; Rai G; Jadhav A; Simeonov A; Holman TR; Maloney DJ; Boutaud O; Holinstat M
Mol Pharmacol; 2012 Mar; 81(3):420-30. PubMed ID: 22155783
[TBL] [Abstract][Full Text] [Related]
8. First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis.
Adili R; Tourdot BE; Mast K; Yeung J; Freedman JC; Green A; Luci DK; Jadhav A; Simeonov A; Maloney DJ; Holman TR; Holinstat M
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1828-1839. PubMed ID: 28775075
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.
Luci DK; Jameson JB; Yasgar A; Diaz G; Joshi N; Kantz A; Markham K; Perry S; Kuhn N; Yeung J; Kerns EH; Schultz L; Holinstat M; Nadler JL; Taylor-Fishwick DA; Jadhav A; Simeonov A; Holman TR; Maloney DJ
J Med Chem; 2014 Jan; 57(2):495-506. PubMed ID: 24393039
[TBL] [Abstract][Full Text] [Related]
10. Future innovations in anti-platelet therapies.
Barrett NE; Holbrook L; Jones S; Kaiser WJ; Moraes LA; Rana R; Sage T; Stanley RG; Tucker KL; Wright B; Gibbins JM
Br J Pharmacol; 2008 Jul; 154(5):918-39. PubMed ID: 18587441
[TBL] [Abstract][Full Text] [Related]
11. P2Y
Hensch NR; Karim ZA; Pineda J; Mercado N; Alshbool FZ; Khasawneh FT
Biochem Biophys Res Commun; 2017 Nov; 493(2):1069-1074. PubMed ID: 28928091
[TBL] [Abstract][Full Text] [Related]
12. Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'.
Kraft P; De Meyer SF; Kleinschnitz C
J Cereb Blood Flow Metab; 2012 Oct; 32(10):1831-40. PubMed ID: 22805877
[TBL] [Abstract][Full Text] [Related]
13. 15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension.
Shen T; Shi J; Wang N; Yu X; Zhang C; Li J; Wei L; Ma C; Zhao X; Lian M; Jiang C; Zhu D
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(5):L449-62. PubMed ID: 26092993
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the biosynthesis of prostanoids and hydroxyeicosatetraenoic acids in human whole blood and platelets by targeted chiral lipidomics analysis.
Tacconelli S; Fullone R; Dovizio M; Pizzicoli G; Marschler S; Bruno A; Zucchelli M; Contursi A; Ballerini P; Patrignani P
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158804. PubMed ID: 32853794
[TBL] [Abstract][Full Text] [Related]
15. The Antithrombotic Agent Pterostilbene Interferes with Integrin α
Huang WC; Lin KC; Hsia CW; Hsia CH; Chen TY; Bhavan PS; Sheu JR; Hou SM
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807403
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
[TBL] [Abstract][Full Text] [Related]
17. Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation.
Yeung J; Tourdot BE; Fernandez-Perez P; Vesci J; Ren J; Smyrniotis CJ; Luci DK; Jadhav A; Simeonov A; Maloney DJ; Holman TR; McKenzie SE; Holinstat M
Blood; 2014 Oct; 124(14):2271-9. PubMed ID: 25100742
[TBL] [Abstract][Full Text] [Related]
18. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K
Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149
[TBL] [Abstract][Full Text] [Related]
19. Interruption of thrombosis and hemostasis by anti-platelet agents.
Shebuski RJ
Toxicol Pathol; 1993; 21(2):180-9. PubMed ID: 8210940
[TBL] [Abstract][Full Text] [Related]
20. Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis.
Koupenova M; Clancy L; Corkrey HA; Freedman JE
Circ Res; 2018 Jan; 122(2):337-351. PubMed ID: 29348254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
